Q

Qiagen NV

QGEN

45.810
USD
1.31
(2.94%)
مفتوح الان
حجم التداول
10,960
الربح لكل سهم
0
العائد الربحي
0
P/E
122
حجم السوق
9,387,586,560
أصول ذات صلة
A
1.430
(1.01%)
142.860 USD
A
ALpA
-0.240
(-0.94%)
25.420 USD
BDX
-4.995
(-2.07%)
236.055 USD
F
FAST
-3.350
(-4.73%)
67.430 USD
H
HOLX
1.610
(1.97%)
83.220 USD
H
HUBB
-15.47
(-3.91%)
379.77 USD
I
IDXX
1.95
(0.41%)
477.81 USD
NVDA
-7.750
(-6.62%)
109.380 USD
TMO
9.03
(1.47%)
621.78 USD
الأخبار المقالات

العنوان: Qiagen NV

القطاع: Healthcare
الصناعة: Diagnostics & Research
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).